![]() |
產(chǎn)地 | 進口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS10442 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 |
CAS編號 | |
抗體名 | Anti-PANK2 |
克隆性 | |
靶點 | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human PANK2 |
中文名稱 泛酸激酶2抗體規(guī)格
英文名稱 Anti-PANK2
別 名 C20orf48; HARP; hPANK2; HSS; MGC15053; NBIA1; PANK2; PANK2_HUMAN; Pantothenate kinase 2 (Hallervorden Spatz syndrome); Pantothenate kinase 2; Pantothenic acid kinase 2; PKAN; RP23 387C21.4.
產(chǎn)品屬性:
泛酸激酶2抗體規(guī)格 濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse
產(chǎn)品類型 一抗
研究領(lǐng)域 細胞生物 免疫學(xué) 神經(jīng)生物學(xué) 信號轉(zhuǎn)導(dǎo)
蛋白分子量 predicted molecular weight: 57kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human PANK2
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
泛酸激酶2抗體規(guī)格 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Defects in PANK2 are the cause of neurodegeneration with brain iron accumulation type 1 (NBIA1); also known as pantothenate kinase-associated neurodegeneration (PKAN) or Hallervorden-Spatz syndrome (HSS). It is an autosomal recessive neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. Clinical manifestations include progressive muscle spasticity, hyperreflexia, muscle rigidity, dystonia, dysarthria, and intellectual deterioration which progresses to severe dementia over several years. It is clinically classified into classic, atypical, and intermediate phenotypes. Classic forms present with onset in the first decade, rapid progression, loss of independent ambulation within 15 years. Atypical forms have onset in the second decade, slow progression, maintenance of independent ambulation up to 40 years later. Intermediate forms manifest onset in the first decade with slow progression or onset in the second decade with rapid progression. Patients with early onset tend to also develop pigmentary retinopathy, whereas those with later onset tend to also have speech disorders and psychiatric features. All patients have the 'eye of the tiger' sign on brain MRI.
Defects in PANK2 are the cause of hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP). HARP is a rare syndrome with many clinical similarities to NBIA1.
Function : May be the master regulator of the CoA biosynthesis (By similarity).
Subunit :
Isoform 2: Cytoplasm (Potential).
Tissue Specificity : Ubiquitous.
DISEASE : Defects in PANK2 are the cause of neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200]; also known as pantothenate kinase-associated neurodegeneration (PKAN) or Hallervorden-Spatz syndrome (HSS). It is an autosomal recessive neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. Clinical manifestations include progressive muscle spasticity, hyperreflexia, muscle rigidity, dystonia, dysarthria, and intellectual deterioration which progresses to severe dementia over several years. It is clinically classified into classic, atypical, and intermediate phenotypes. Classic forms present with onset in the first decade, rapid progression, loss of independent ambulation within 15 years. Atypical forms have onset in the second decade, slow progression, maintenance of independent ambulation up to 40 years later. Intermediate forms manifest onset in the first decade with slow progression or onset in the second decade with rapid progression. Patients with early onset tend to also develop pigmentary retinopathy, whereas those with later onset tend to also have speech disorders and psychiatric features. All patients have the 'eye of the tiger' sign on brain MRI.
Defects in PANK2 are the cause of hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP) [MIM:607236]. HARP is a rare syndrome with many clinical similarities to NBIA1.
Similarity : Belongs to the type II pantothenate kinase family.
Database links : UniProtKB/Swiss-Prot: Q9BZ23.3
實驗流程:
全、新、優(yōu)、品、好四大特點:
泛酸激酶2抗體規(guī)格 全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團隊,產(chǎn)品一旦售出,實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
技術(shù)外包服務(wù):
★泛酸激酶2抗體規(guī)格 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程:原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程:細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。
正在熱銷的相關(guān)產(chǎn)品:
SP-B(Human Pulmonary surfatcant-associated protein B) ELISA Kit 人肺表面活性物質(zhì)相關(guān)蛋白BMulti-class antibodies規(guī)格: 48T
Anti-HPV16 E6 + HPV18 E6 人類狀瘤病毒16/18 E6抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh MCC 突變蛋白抗體 規(guī)格 0.2ml
ICE(Human Interleukin 1 Beta converting enzyme) ELISA Kit 人白介素1β轉(zhuǎn)換酶 96T
RNF70 英文名稱: 環(huán)指蛋白70抗體 0.2ml
Actin Regulatory Protein CAPG 英文名稱: 肌動蛋白調(diào)節(jié)蛋白CAPG抗體 0.2ml
Anti-HPV16 E6 + HPV18 E6 人類狀瘤病毒16/18 E6抗體Multi-class antibodies規(guī)格: 0.2ml
Beta-EPR ELISA Kit 大鼠β內(nèi)啡肽受體Multi-class antibodies規(guī)格: 48T
Anti-CD94/KLRD1 NK細胞表面抑制性受體CD94抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh GM130 高爾基體自身蛋白GM130抗體 規(guī)格 0.2ml
IMA(Mouse Ischemia Modified Albumin) ELISA Kit 小鼠缺血修飾白蛋白 96T
Neuritin 英文名稱: 轉(zhuǎn)化神經(jīng)突起蛋白抗體 0.2ml
ASC 英文名稱: 凋亡相關(guān)斑點樣蛋白ASC抗體 0.1ml
Anti-CD94/KLRD1 NK細胞表面抑制性受體CD94抗體Multi-class antibodies規(guī)格: 0.2ml
Anti-IL-1RA (Interleukin-1 receptor antagonist) /FITC 熒光素標(biāo)記兔抗人、大、小鼠、豬、、羊、犬白介素-1受體拮抗劑抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-PP-2A/FITC 熒光素標(biāo)記蛋白質(zhì)磷酸酶-2A抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh ARF6 ADP核糖基化因子6抗體 規(guī)格 0.2ml
Rabbit Anti-Mink IgG/Cy3 Cy3標(biāo)記的兔抗水貂IgG 0.1ml
GDI1 英文名稱: 精神發(fā)育遲滯相關(guān)蛋白Rab GDI α抗體 0.2ml
Rhesus antibody Rh Rabbit Anti-Mink IgG/HRP 辣根過氧化物酶標(biāo)記的兔抗水貂IgG 規(guī)格 0.1ml
Anti-PP-2A/FITC 熒光素標(biāo)記蛋白質(zhì)磷酸酶-2A抗體IgGMulti-class antibodies規(guī)格: 0.2ml
大鼠降鈣素原(PCT)ELISA試劑盒 96T/48T 試劑盒 組裝/原裝
人熱休克蛋白70(HSP-70)抗體免疫試劑盒 Human Heat Shock Protein 70(HSP-70)aibody ELISA Kit
MouseLeptinSolubleReceptor,sLRELISAKit小鼠可溶性瘦素受體(sLR)ELISA試劑盒規(guī)格:96T/48T
IL-13(抗人;抗兔;抗小鼠;抗大鼠)100微克
Humanneurofilameprotein,NFELISA試劑盒人神經(jīng)絲蛋白(NF)ELISA試劑盒規(guī)格:96T/48T
HumanProteinase3Aibody,PR3AbELISAKit人抗肝可溶性抗原抗體(SLA)ELISA試劑盒規(guī)格:96T/48T
大鼠艾杜糖酯酶(IDS)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝
人磷酯酰肌醇特異性磷酯酶C(PIPLC)免疫試劑盒 Human phosphoinositide-specific phospholipase C,PIPLC ELISA Kit
PorcineAngiopoietin1,ANG-1ELISAKit豬生成素1(ANG-1)ELISA試劑盒規(guī)格:96T/48T
石蠟切片組織蛋白表達NBT顯色光學(xué)顯微鏡檢測試劑盒-LEPTIN10/20次
HumaeninELISA試劑盒人腎素(Renin)ELISA試劑盒規(guī)格:96T/48T
Humaumornecrosisfactor-relatedapoptosis-inducingligand1,AIL-R1ELISAKit人壞死因子相關(guān)凋亡誘導(dǎo)配體1(AIL-R1)ELISA試劑盒規(guī)格:96T/48T
泛酸激酶2抗體規(guī)格 大鼠苯酚磺基轉(zhuǎn)移酶(PST)ELISA試劑盒 ,英文名: PST ELISA Kit
Rat follicle stimulating hormone (FSH) ELISA Kit 大鼠促卵泡素(FSH)ELISA試劑盒
Ratalcoholdehydrogenase,ADHELISAKit 大鼠乙醇脫輕酶(ADH)ELISA試劑盒 96T/48T 進口分裝
CLIAKitforCollagenaseI(MouseCollagenaseTypeI)ELISAKit小鼠膠原酶I規(guī)格:48T/96T
細胞乙酰膽堿脂酶活性染色試劑盒50次
RatClusterin,CLUELISAKit大鼠凝聚素(CLU)ELISA試劑盒規(guī)格:96T/48T